Another inflammation-associated target is LRG1, mainly contributing to inflammatory diseases such as acute appendicitis [46], inflammatory bowel disease [47], diabetic kidney disease [48], and to various cancer types [49]. This evidence concerns the gene LRG1 and cancer.